GOLDMAN MYLA LAI
CIK 1168581 · EVP & Chief Medical Officer · last filed 2026-07-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$16.08M
Companies
5
Total Filings
63
Lifetime Open-Market Net
-$6.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QTRX | Director | 15,041 | $3.49 | $52.5K | $0 | 4 | 2026-07-09 |
| WST | Director | 20,434 | $337.00 | $6.89M | $0 | 25 | 2026-05-06 |
| Akoya Biosciences, Inc. (AKYA) Delisted | Director | 20,000 | $1.29 | $25.8K | $100.0K | 5 | 2024-06-05 |
| SEQUENOM INC (SQNM) Delisted | Director | 0 | — | — | $18.4K | 10 | 2016-09-07 |
| LH | EVP & Chief Medical Officer | 29,090 | $314.23 | $9.14M | -$6.97M | 18 | 2008-11-24 |
Recent Filings · Page 3 of 7
63 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-10-03 | WST | Grant (A) | — | $0 | EDGAR |
| 2017-07-05 | WST | Grant (A) | — | $0 | EDGAR |
| 2017-05-03 | WST | Grant (A) | +1,697 | $0 | EDGAR |
| 2017-04-04 | WST | Grant (A) | — | $0 | EDGAR |
| 2017-01-04 | WST | Grant (A) | — | $0 | EDGAR |
| 2016-10-04 | WST | Grant (A) | — | $0 | EDGAR |
| 2016-09-07 | SEQUENOM INC (SQNM) Delisted | Mixed | −79,579 | $0 | EDGAR |
| 2016-07-05 | WST | Grant (A) | — | $0 | EDGAR |
| 2016-06-16 | SEQUENOM INC (SQNM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-05 | WST | Grant (A) | +2,262 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.